News & Events

Webinars Available:


Key Considerations for Implementing Rapid Microbial Methods for Mycoplasma Detection

(Previously aired on January 26th, 2021)

Click here to view


For the last several years, Bionique Testing Laboratories has been in a unique position to facilitate the adoption of rapid mycoplasma testing strategies by their clients. Predominantly cell therapy developers motivated by particularly short production schedules and product shelf life, this pool of clients has grown to include raw material providers interested in reducing inventory hold times.

This discussion will cover lessons learned throughout Bionique’s experience with guiding sponsors through the process of developing and qualifying or validating a MycoSEQ-based rapid mycoplasma testing strategy.

In this webinar you will learn the importance of demonstrating product specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence.

Who could benefit?

Anyone considering the adoption of a rapid mycoplasma testing strategy including assay development scientists, QC managers, Global Product Quality leads, and other CMC focused quality professionals.





Bionique in Association with ThermoFisher and American Pharmaceutical Review Present:  Key Considerations for Implementing Rapid Microbial Methods for Mycoplasma Detection  

        For full review of seminar, click here.


Bionique Appoints Gladis Zamparo as new Chief Executive Officer

        See Bionique's press release here.


Bionique's Research Presented in Advances in Biotechnology & Microbiology 

Research conducted at Bionqiue Testing Laboratories was published in an article that studies the impact of aerobicity on colony growth of various mollicutes, including mycoplasma, on agar in order to confirm the optimal oxygen content for colony growth for isolation of mycoplasma from cell cultures for routine subcultivation. The purpose of the study was to continue to be an industry leader and address a lack of information pertaining to the impact of atmospheric testing conditions, aerobic or anaerobic, compared to the industries common standards and good practices. To find out more, see the full article here.




Past Conferences:

BPI US 2020 - September 21-25, 2020

Virtual Attendee

ISCT 2020 - May 27-30, 2020

Virtual Attendee


ASGCT 23rd Annual Meeting - May 12-15, 2020

Vitual Attendee


Phacilitate Leaders World 2020 - Hyatt Regency, Miami, FL, January 21-24, 2020, Booth # W-14




Download Sample Submission Forms